Founder & CEO | Tensegrity Medical: Leading the Next Era of Disruptive BioscienceAs the Founder and CEO of Tensegrity Medical, I am at the forefront of a transformative shift in healthcare. Our mission is to develop groundbreaking, AI-driven biomedical devices that revolutionize patient care and empower individuals to take control of their healing journey.We’re pioneering a disruptive, non-invasive medical device that redefines wound care and pain management. This device optimized care in real-time through machine learning algorithms and AI 🤖 It’s designed to shift the landscape of healthcare from reactive treatments to proactive, patient-driven solutions.Key Responsibilities:• Oversee all phases of product development, from conceptualization to prototyping, in collaboration with NAU’s top engineering and research teams.•Lead strategy in regulatory compliance, IP protection, and commercialization within the biomedical field.•Forge strategic partnerships with Flagstaff’s Economic Development team, Coconino County, Flinn Foundation, AZ BioScience Roadmap, AZ Tech Council, CEI (Center for Entrepreneurship), and Venture Cafe in PHX to position Tensegrity Medical for market success.Key Achievements:• Spearheading the development of a scalable, life-saving device with wide applications across military, first responders, hospitals, and home healthcare settings.• Leading a cross-disciplinary team of 10+ NAU senior students across mechanical, electrical, and computer science engineering to bring innovative light therapy and wound care solutions to market.• Secured collaborations with key stakeholders and other leaders in Arizona’s bioscience community.Skills & Expertise:• Expertise in biomedical device development and non-invasive healthcare solutions.• Proven ability to lead teams in high-stakes, innovation-driven environments.• Skilled in IP strategy, product commercialization, and bioscience ecosystem development.At Tensegrity Medical, we are committed to writing a new chapter in healthcare—one that’s driven by innovation, patient outcomes, and a bold vision for the future of bioscience.